Sorry!! The article you are trying to read is not available now.
Markets
Stocks
Funds
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Recent Quotes
My Watchlist
Indicators
Eli Lilly (NY: LLY)
111.12 USD  +0.99 (+0.90%)
Official Closing Price  /  Updated: 7:54 PM EDT, Sep 17, 2019  /  Add to My Watchlist      
View: Quote News Research
Price and Volume
Detailed Quote
Chart for (: )
 
Intraday
1 Week
1 Month
3 Month
1 Year
  
Compare to:
Volume 2,489,451
Open 110.33
Bid (Size) 110.10 (1)
Ask (Size) 111.53 (1)
Prev. Close 110.13
Today's Range 109.63 - 111.19
52wk Range 104.17 - 132.13
Shares Outstanding 1,085,430,420
Dividend Yield 2.03%
Performance
YTD
-3.27%
-3.27%
1 Month
-1.25%
-1.25%
3 Month
-3.08%
-3.08%
6 Month
-12.22%
-12.22%
1 Year
+5.12%
+5.12%
Featured News
More News
Gilead and Amgen will report second-quarter earnings after the closing bell. Here’s what to expect
Drugmakers Gilead Sciences Inc. and Amgen Inc. are scheduled to report earnings Tuesday after the market close. Read More
category Medical Products , GLPG , MRK , and 18 more.
from MarketWatch
Stocks set to slump as weak earnings weigh
U.S. stocks were poised to fall Tuesday as a batch of weak corporate results helped to set a downbeat tone on Wall Street. Read More
category PG , YMU19 , Market News , and 17 more.
from MarketWatch
Featured News
Read More
There’s a generational shift in the Fed’s thinking, and here’s what it means for stocks
category AAPL , COF , CL/1 , and 15 more.
from MarketWatch
The earnings menu: Beyond Meat, Apple and a big bag of chips
category Medical Products , INTC , BMY , and 61 more.
from MarketWatch
Allergan acquisition is ‘a major bailout’ for shareholders, according to analysts
category EOLS , Medical Products , IT:NESN , and 16 more.
from MarketWatch
Shares of cancer-therapy companies skyrocket after Pfizer acquisition news
category General , AMGN , Health/Care , and 19 more.
from MarketWatch
Drugmakers file lawsuit to block rule requiring drug prices in TV ads
category LLY , Biotechnology , MRK , and 2 more.
from MarketWatch
Amgen, Biogen, Gilead and Novo Nordisk have ‘very high’ capacity for M&A, says Moody’s
category Analyst Research/Ratings , NVO , TAK , and 23 more.
from MarketWatch
More News
Read More
Lilly Announces Positive Results for Selpercatinib (LOXO-292), Demonstrating a 68 Percent Objective Response Rate and Sustained Durability in Heavily Pretreated RET Fusion-Positive Non-Small Cell Lung
from PR Newswire
Biotech Stock On The Radar: vTv Therapeutics' Diabetes Pipeline
category LXRX , Trading Ideas , VTVT , and 13 more.
from Benzinga
UPDATE 2-Biogen scraps two late-stage trials for Alzheimer's treatment
category companyNews
from Reuters: Company News
How This Pharma Stock Could Knock Eli Lilly Off Its Diabetes Pedestal
from Investor's Business Daily
UPDATE 1-Purdue OxyContin settlement would rank among largest in pharma history
category companyNews
from Reuters: Company News
Here's Why Alder Biopharmaceuticals Is Rocketing Higher Today
category ALDR , LLY , AMGN , and 2 more.
from Motley Fool
UPDATE 2-Xeris Pharma's low blood sugar treatment wins FDA approval
category companyNews
from Reuters: Company News
This Biotech Stock Just Rocketed 83% On A $2 Billion Takeover Deal
from Investor's Business Daily
UPDATE 1-Xeris Pharma's low blood sugar treatment wins FDA approval
category companyNews
from Reuters: Company News
Notable ETF Outflow Detected - ACWI, HON, LLY, ABBV
category ETFs
from ETF Channel
Humira Sales Will Crash To $3 Billion — Why AbbVie Stock Got An Upgrade
from Investor's Business Daily
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Six Financial & Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.

WHAT'S POPULAR IN THE VILLE